Background illustration for clinical trials search

Paid Clinical Trials Georgia

Discover 1,918 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

for
Hemorrhagic Stroke, Aneurysm, Intracranial, Saccular Aneurysm,
Location: Boston MA, Stony Brook NY, Manhasset NY, New York NY,
Sponsor: phenox Inc.

Sex: All

Age: 18+

Code: NCT07143019

Recruiting

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Burlington MA, Bridgeport CT, Brooklyn NY, Annapolis MD,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, The Bronx NY, Philadelphia PA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18 - 70+

Code: NCT07219212

Phase 1, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Worcester MA, Hartford CT, Norwalk CT, Danbury CT,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase 3, Recruiting

Harnessing Communication Preferences

for
Intellectual Disability, Autism Spectrum Disorder,
Location: Athens GA, Iowa City IA
Sponsor: Joel E. Ringdahl

Sex: All

Age: 2 - 70+

Code: NCT07278544

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, Manhasset NY,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase 3, Recruiting

Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos

for
Complex Aneuploidy, Chaotic Aneuploidy
Location: Chesterbrook PA, Norfolk VA, Towson MD, Rockville MD,
Sponsor: Shady Grove Fertility Reproductive Science Center

Sex: All

Age: 0+

Code: NCT07227116

Recruiting

Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial

for
Advanced Acral Melanoma, Advanced Cutaneous Melanoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07155317

Phase 2, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Scarborough ME, Providence RI, Farmington CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase 3, Recruiting

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

for
Hypertension, Uncontrolled Hypertension
Location: Norfolk VA, Kinston NC, Burke VA, Charleston SC,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07090161

Phase 2, Recruiting

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

for
Glanzmann Thrombasthenia
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT07136857

Phase 2, Recruiting

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

for
Extensive-stage Small-cell Lung Cancer
Location: Burlington MA, White Plains NY, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712355

Phase 3, Recruiting

Optimizing Strategies to Maximize Patient Recruitment Yield

for
Recruitment
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07290335

Recruiting

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

for
Aortic Arch Aneurysm, Aortic Arch Dissection,
Location: The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Artivion Inc.

Sex: All

Age: 18 - 70+

Code: NCT07089576

Recruiting

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

for
Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer,
Location: Lebanon NH, Atlanta GA, Milwaukee WI, Honolulu HI
Sponsor: OncoTherapy Science, Inc.

Sex: All

Age: 18+

Code: NCT02926690

Phase 1, Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Montreal, Washington D.C. DC, Toronto, Atlanta GA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT04901702

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Quebec, New York NY, Saint-Charles-Borromee,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07088926

Phase 2, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Halifax, Providence RI, Quebec, Sherbrooke, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase 3, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Moncton, Quebec, The Bronx NY, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

for
Locally Advanced Urothelial Carcinoma,
Location: Worcester MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06524544

Phase 3, Recruiting

Popular cities in Georgia

AthensSandy SpringsAtlantaNewnanAugustaSavannah